Crossmark

Artesunate targets oral tongue squamous cell carcinoma via mitochondrial dysfunction-dependent oxidative damage and Akt/AMPK/mTOR inhibition

Published Online: 2020-01-21

Published Print: 2020-04

Authors

Xiao, Qingfeng

Yang, Lei

Hu, Hao https://orcid.org/0000-0001-8751-7069
Ke, Yue
Funding

Funding for this research was provided by:

Health and Family Planning Commission of Hubei Province (2016XW166)
License Information

Text and Data Mining valid from 2020-01-21

Version of Record valid from 2020-01-21
More Information

Article History

Received: 22 May 2019

Accepted: 13 January 2020

First Online: 21 January 2020

Compliance with ethical standards

:

: All authors declare no conflict of interest.

: All applicable international, national, and/or institutional guidelines for the care and use of animals were followed.

Document is current